Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-01

Clinical Trial Update: 2017 A/H7N9 IIV Revaccination [Phase 2]

View source ↗

Summary

Phase 2 trial update on revaccination with A/H7N9 influenza vaccine shows completed status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Avian Influenza, Influenza Immunisation | Phase 2 | Status: COMPLETED | Results posted: 2021-07-01